Search - tctmd.com

Displaying 361 - 380 of 445

Sort: Relevancy | Date

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Oral Sirolimus Appears to Augment Efficacy of BMS

Caitlin E. Cox

August 23, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Jason Kahn

August 05, 2013

News Daily News

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Jason Kahn

August 05, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

News Daily News

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

L.A. McKeown

July 05, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

Obesidad Mórbida: Un Factor de Riesgo, en Aumento, en Pacientes con PCI

L.A. McKeown

June 20, 2013

News Daily News

Morbid Obesity: An Increasing Risk Factor in PCI Patients

L.A. McKeown

June 20, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

May 13, 2013

Advertisement

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Oral Sirolimus Appears to Augment Efficacy of BMS

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Apixaban Reduce el Índice de Hospitalizaciones compardo con la Aspirina en Pacientes con Fibrilación Auricular

Apixaban Lowers Hospitalization Rate vs. Aspirin in A-fib Patients

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

El Apixaban No es Inferior a la Terapia Estándar en el Tratamiento de los Tromboembolismos Venosos Agudos

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

Obesidad Mórbida: Un Factor de Riesgo, en Aumento, en Pacientes con PCI

Morbid Obesity: An Increasing Risk Factor in PCI Patients

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content